IN BRIEF: Amryt Pharma delists from AIM as trading shifts to New York
11th Jan 2022 14:39
IN BRIEF: Amryt Pharma delists from AIM as trading shifts to New York Read More
AMYT.L (AMYT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
AMYT.L (AMYT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 6th Jan 2022 5:30 pm | RNS | Amryt Pharma |
| 6th Jan 2022 7:00 am | GNW | Key Dates for AIM Delisting |
| 4th Jan 2022 12:00 pm | GNW | The Lancet Diabetes & Endocrinology Publishes Positive Results for the MPOWERED Phase 3 Trial for Mycapssa® (oral octreotide) in Acromegaly Patients |
| 4th Jan 2022 7:00 am | GNW | Total Voting Rights |
| 1st Dec 2021 7:00 am | GNW | Total Voting Rights |
| 30th Nov 2021 7:00 am | GNW | Director/PDMR Shareholding |
| 23rd Nov 2021 12:00 pm | GNW | Amryt Provides Update on Regulatory Review Process for Oleogel-S10 |
| 22nd Nov 2021 7:00 am | GNW | Amryt Announces the Cancellation of Admission of its Ordinary Shares to Trading on AIM |
| 3rd Nov 2021 11:00 am | GNW | Amryt Reports Strong Q3 2021 Results |
| 1st Nov 2021 1:00 pm | GNW | Total Voting Rights |